The U.S. Food and Drug Administration has approved Vyvanse for the treatment of attention-deficit/hyperactivity disorder in adults. Vyvanse is a new amphetamine-based med. Its maker, Shire, intends to market Vyvanse as a replacement for Adderall XR.
Read moreA question we sometimes receive on ADHD Central is about whether or not stuttering is somehow associated with having ADHD. Some of you... Read more »
Last week I wrote a post entitled, "Why Some People Don't Believe in ADHD" which generated a lot of discussion among our members on ADHD... Read more »
Reprinted with permission of Amy Tenderich of diabetesmine.com. Remember that little discussion about abandoning the established A1c for a... Read more »
I often go out of my way to avoid movies and tv shows that portray women struggling with breast cancer, but I was taken in by some of the... Read more »
Here are a couple of issues to reflect on as we move toward Election Day: (1) In California, Proposition 4 will be back on the... Read more »
Vyvanse is effective in treating adults with attention-deficit/hyperactivity disorder, according to new clinical trial results. In the study, 414... Read more »
Shire, the maker of Vyvanse, has filed for U.S. approval to treat adult attention-deficit/hyperactivity disorder with their new ADHD medication.... Read more »
According to the drug manufacturer Shire, the Food and Drug Administration has approved Vyvanse for the treatment of attention-deficit/hyperactivity... Read more »
Brand Name: Adderall and Adderall XR Generic Name: amphetamine, dextroamphetamine Usage: Adderall and Adderall XR have been approved by the... Read more »
Brand Name: Vyvanse Generic Name: lisdexamfetamine dimesylate Usage: Vyvanse has been approved by the Food and Drug Administration to treat... Read more »